Patent details

300801 Product Name: Obinutuzumab

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
300801
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP2380910
Status:
SPC in force
Application number:
300801
Procedural language:
Dutch
First Applicant Residence Country:
Switzerland (CH)

Marketing Authorization

Marketing Authorization Number:
EU/1/14/937
Marketing Authorization Type:
EEA
Marketing Authorization Date:
24/07/2014
Marketing Authorization Country:
European Union (EU)

Dates

Filing date:
16/03/2016
First Marketing Authorization date:
24/07/2014
Grant date:
19/09/2017
Activation date:
05/11/2024
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
11/04/2016
SPC/SPC Extension Expiration Date:
23/07/2029
Lapsed By Expiration Date:
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:

Applicant/holder

From:
25/03/2016
 
 

 

Name:
Roche Glycart AG
Address:
Wagistrasse 18, 8952 SCHLIEREN-ZUERICH, Switzerland (CH)

Agent

1

Name:
ir. B.Ch. Ledeboer c.s
From:
28/07/2025
Address:
V.O. Postbus 87930, 2508 DH, Den Haag, Netherlands (NL)
To:

2

Name:
ir. H.A. Witmans c.s.
From:
25/03/2016
Address:
V.O. Postbus 87930, 2508 DH, Den Haag, Netherlands (NL)
To:
28/07/2025

Publication

Bulletin

1

Bulletin Heading:
SPC
Journal edition number:
45/24
Publication date:
06/11/2024
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

2

Bulletin Heading:
SPC
Journal edition number:
38/17
Publication date:
20/09/2017
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

3

Bulletin Heading:
SPC
Journal edition number:
15/16
Publication date:
13/04/2016
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

Annual Fee

Annual Fee(s) Due Date:
30/11/2026
Annual Fee Number:
23
Annual Fee Amount:
2000 Euro
Last Annual Payment Date:
23/07/2025
Last Annual Fee Paid Number:
22
Last Annual Fee Paid Amount:
1800 Euro
Payer:
Anaqua Services
Filing date Document type Document Description Number of pages File Type
19/09/2017 SPC Documents Certificate SPC 1 PDF /7/7/4/0/4/0800040477/docs/300801_3_supplprotectioncertificate20180614021808309.pdf
19/09/2017 Outgoing Correspondence Decision grant 1 PDF /7/7/4/0/4/0800040477/docs/300801_9_outgoingcorrespondence20180614021808216.pdf
07/09/2017 SPC Documents Accompanying letter SPC 1 PDF /7/7/4/0/4/0800040477/docs/300801_4_supplprotectioncertificate20210106024120002.pdf
20/07/2017 Outgoing Correspondence Letter to applicant 1 PDF /7/7/4/0/4/0800040477/docs/300801_0_outgoingcorrespondence20170724102414821.pdf
12/04/2016 Outgoing Correspondence Confirmation receipt request 1 PDF /7/7/4/0/4/0800040477/docs/300801_6_outgoingcorrespondence20210106023545371.pdf
16/03/2016 Application Form First filed application form 3 PDF /7/7/4/0/4/0800040477/docs/300801_1_applicationform20160325013123608.pdf
16/03/2016 SPC Documents Marketing Authorization SPC 3 PDF /7/7/4/0/4/0800040477/docs/300801_2_supplprotectioncertificate20160325013123889.pdf
16/03/2016 SPC Documents Annex SPC 19 PDF /7/7/4/0/4/0800040477/docs/300801_5_supplprotectioncertificate20210106023042433.pdf
16/03/2016 SPC Documents Summary of the characteristics of the product 22 PDF /7/7/4/0/4/0800040477/docs/300801_7_supplprotectioncertificate20210106023042285.pdf
16/03/2016 SPC Documents Annex SPC 3 PDF /7/7/4/0/4/0800040477/docs/300801_8_supplprotectioncertificate20210106023042373.pdf